Australia’s ASX looks well supported

The ASX rally looks to be well supported on the technical charts, even though valuations are looking stretched. Whitehaven Coal, Asaleo Care and Regis all have momentum.

ASX
Source: Bloomberg

The technicals are lining up behind the ASX, supporting a move higher after last week’s strong performance. The ASX managed its first close above 5400 since 12 August on Friday, a hugely significant psychological level for the market. Market internals indicators are showing that the move has been widely supported by a range of companies, showing that there is significant market breadth behind the move. While valuations are looking stretched, the technicals are pointing higher in a week that will be buffeted by the release of a range of economic data.

Pacific Brands agreed to a A$1.15 a share buyout from US-based Hanesbrands, but short positions in the stock saw the biggest rise in the ASX index over the past week. Orora, the packaging company, also saw a noticeable increase in short positions. And the rise in short positions in Woodside and Caltex may indicate growing investor caution as the spot oil price struggles to break above US$50.

After seven straight days of declines, investors have started closing their short positions in APN Outdoor. Westfield’s past week of gains also looks to have cooled the bears as they closed out a lot of short positions.

Top momentum picks:

Whitehaven Coal has been enjoying the bounce in coal prices since April. Even though spot coal prices have dropped back from their highs, they look to be stabilising at substantially higher levels than earlier in the year. Whitehaven’s stock has decisively broken above A$0.80, and it looks like it has the momentum to see it test A$1.00. Currently, eight analysts have the stock at buy, two at hold, and three at sell.

Asaleo Care, which manufactures a range of personal care and hygiene products, is still very much in an uptrend. It failed to close above A$2.10 on 19 May, but its stock price surged over 2% on Friday and it looks primed for a retest of A$2.10 this week. Two analysts have the stock at buy, three at hold, and one at sell.

Regis is still stuck in a downtrend. After bouncing off A$4.65, it has been rejected at A$5.06. The stock is looking increasingly hemmed in by its 50-day moving average and there’s a good chance it pulls lower again. Currently, two analysts have the stock at Buy, five at Hold and one at Sell.

To subscribe to IG’s ASX reports, email “subscribe” to insto.research.au@ig.com.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.